Hemoglobin A1c Reduction With the GLP-1 Receptor Agonist Semaglutide Is Independent of Baseline eGFR: post hoc Analysis of the SUSTAIN and PIONEER Programs
| Autor: | Cherney, David Z.I., Hadjadj, Samy, Lawson, Jack, Mosenzon, Ofri, Tuttle, Katherine, Vrhnjak, Blaz, Rasmussen, Søren, Bain, Stephen C. |
|---|---|
| Zdroj: | In Kidney International Reports November 2022 7(11):2345-2355 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|